179
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and tolerability of lercanidipine in patients with hypertension: results of a Phase IV study in general practice

, MD FASN & , MD
Pages 2215-2223 | Published online: 10 Oct 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Michel Burnier, Menno Pruijm & Gregoire Wuerzner. (2009) Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?. Expert Opinion on Drug Metabolism & Toxicology 5:8, pages 981-987.
Read now
Menno T Pruijm, Marc P Maillard & Michel Burnier. (2008) Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine. Vascular Health and Risk Management 4:6, pages 1159-1166.
Read now

Articles from other publishers (9)

Sonam Grewal, Sukhbir Singh, Neelam Sharma, Tapan Behl, Ikmeet Kaur Grewal & Sumeet Gupta. (2023) Insights into the Pivotal Role of Calcium Channel Blockers and Its Nanoformulations in the Management of Hypertension. BioNanoScience 13:4, pages 1437-1462.
Crossref
Marina G. Bubnova. (2022) Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review. CardioSomatics 13:1, pages 31-42.
Crossref
A Reum Lee, Min Ji Seo, Jin Kim, Dong Min Lee, In Young Kim, Mi Jin Yoon, Hur Hoon & Kyeong Sook Choi. (2019) Lercanidipine Synergistically Enhances Bortezomib Cytotoxicity in Cancer Cells via Enhanced Endoplasmic Reticulum Stress and Mitochondrial Ca2+ Overload. International Journal of Molecular Sciences 20:24, pages 6112.
Crossref
F. Fici, G. Seravalle, N. Koylan, I. Nalbantgil, N. Cagla, Y. Korkut, F. Quarti-Trevano, W. Makel & G. Grassi. (2017) Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up. High Blood Pressure & Cardiovascular Prevention 24:3, pages 289-296.
Crossref
M. Burnier, Y. Vuignier & G. Wuerzner. (2013) State-of-the-art treatment of hypertension: established and new drugs. European Heart Journal 35:9, pages 557-562.
Crossref
Viktor Viktorovich Fomin & Sergey Valentinovich Moiseev. (2013) Sovershenstvovanie podkhodov k primeneniyu antagonistov kal'tsiya: fokus na lerkanidipin. CardioSomatics 4:3, pages 42-45.
Crossref
A. Schattner. (2011) Lercanidipine-associated nocturia. QJM 104:5, pages 463-463.
Crossref
Christos ChatzikyrkouHermann HallerJan Menne. (2009) Fixed-dose combination of lercanidipine/enalapril in the treatment of hypertension in the elderly. Aging Health 5:2, pages 141-149.
Crossref
Christos ChatzikyrkouHermann HallerJan Menne. (2009) Efficacy and safety of fixed-dose Lercanidipine-Enalapril for the treatment of hypertension. Clinical Medicine. Therapeutics 1, pages CMT.S2315.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.